Artemether + Lumefantrine

Malaria kills twice as many people every year as formerly believed, taking 1.2 million lives and causing the deaths not only of babies but also older children and adults, according to research that overturns decades of assumptions about one of the world's most lethal diseases.
Malaria is caused by parasites that are spread by mosquitoes, and even in relatively mild cases it can cause high fever, chills, flu-like symptoms, and anemia, which can be especially dangerous for pregnant women. Children who survive severe malaria can suffer lifelong mental disabilities. Malaria’s economic impact is estimated to cost billions of dollars in lost productivity every year.
Malaria is curable and ZERAMAL QS is the solution.

Zeramal QS is a fixed-dose combination tablet of artemether and lumefantrine. Artemether is a methyl ether derivative of dihydroartemisinin derived from artemisinin.
Lumefantrine is a racemic2, 4, 7, 9-substituted fluorine derivative that conforms structurally, physicochemically and in mode of action to the arylamino alcohol group of antimalarials that includes quinine and mefloquine.